共 448 条
- [41] Khan Z(2019)Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression Br J Cancer 120 16-1944
- [42] Noonan KA(2020)Myeloid cell-derived arginase in cancer immune response Front Immunol 11 938-751
- [43] Cao Y(2019)More than just attractive: How CCL2 influences myeloid cell behavior beyond chemotaxis Front Immunol 10 2759-12345
- [44] Trillo-Tinoco J(2021)Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells Nat Immunol 22 947-4151
- [45] Sierra RA(2009)Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells J Immunol 183 937-1791
- [46] Chen J(2021)Landscape of myeloid-derived suppressor cell in tumor immunotherapy Biomark Res 9 77-1581
- [47] Sun HW(2020)TIGIT as an emerging immune checkpoint Clin Exp Immunol 200 108-215
- [48] Yang YY(2009)Oral administration of a soluble 1–3, 1–6 β-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice Int Immunopharmacol 9 1298-e737
- [49] Cheng P(2017)Tadalafil has biologic activity in human melanoma. Results of a pilot trial with Tadalafil in patients with metastatic Melanoma (TaMe) Oncoimmunology. 6 e1326440-272
- [50] Corzo CA(2018)The unfolded protein response and cell fate control Mol Cell 69 169-2312